Irma M. Tsiskaridze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irma M. Tsiskaridze has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Telman A. Simonyan
Bakoulev National Medical Research Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation
3 shared publications - A.A. Fadeev
National Medical Research Center for Cardiovascular Surgery named after A.N. Bakulev, Ministry of Health of the Russian Federation, Moscow
2 shared publications - Alexander Yu. Gorodkov
National Medical Research Center for Cardiovascular Surgery named after A.N. Bakulev, Ministry of Health of the Russian Federation, Moscow
2 shared publications - D. V. Mrikaev
National Medical Research Center for Cardiovascular Surgery named after A.N. Bakulev, Ministry of Health of the Russian Federation, Moscow
2 shared publications - G.V. Danilov
National Medical Research Center for Cardiovascular Surgery named after A.N. Bakulev, Ministry of Health of the Russian Federation, Moscow
2 shared publications - I. Yu. Farulova
ФГБУ «Национальный медицинский исследовательский центр сердечно-сосудистой хирургии им. А.Н. Бакулева» Минздрава России, Москва, Российская Федерация
2 shared publications
Latest Publications
- 1 January 2026
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 14 (3)
The first experience of using a 3D support contour for tricuspid annuloplasty in an experiment
- 1 January 2026
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 14 (3)
The first experience of using a 3D support contour for tricuspid annuloplasty in an experiment
- Open Access
- 1 July 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (3) , 127-132
SURGICAL TREATMENT OF INVASIVE CARDIAC LIPOMA: CASE REPORT
HighlightsInvasive cardiac lipoma is a rare benign cardiac tumor that can cause life-threatening conditions depending on its size and location. This article reports a rare case of surgical treatment of an invasive lipoma of the right atrium. AbstractThe aim of this research is to demonstrate a rare case of surgical treatment of an invasive lipoma of the right atrium. Patient Ya., female, 46 years old, was admitted to the department with periodic attacks of rapid arrhythmic heartbeat. ECG: the rhythm is regular, sinus, 79 beats/min heart rate. According to transthoracic echocardiography: an additional floating heterogeneous formation of a round shape with an uneven contour, measuring 32 × 29 mm, attached to the junction of the superior vena cava was visualized and it was placed in the cavity of the right atrium. According to the results of CT and MRI with contrast the cardiac tumor growing into the right atrium wall and extracardially was also visualized. An operation was performed to remove the cardiac tumor of the right atrium, to reconstruct the right atrium with a xenopericardial patch and de Vega tricuspid valve annuloplasty on the beating heart with cardiopulmonary bypass (77 minutes). The size of the outer part of the tumor was 30 × 70 mm, the inner – 40 × 50 mm. The postoperative period proceeded without complications. Microscopic examination of cardiac tumor showed a histological picture of a cardiac lipoma. In conclusion, it should be noted that invasive lipoma of the right atrium is a rare benign tumor of the heart and this research is of scientific interest for the further study of this phenomenon. Early surgical removal of the lipoma is important, taking into account its characteristics, due to the possible risk of tumor growth and infiltration into the surrounding structure. Preoperative planning requires accurate data on the location of the tumor and its infiltration into the adjacent heart structure.
- 1 July 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (3) , 127-132
Open AccessSURGICAL TREATMENT OF INVASIVE CARDIAC LIPOMA: CASE REPORT
HighlightsInvasive cardiac lipoma is a rare benign cardiac tumor that can cause life-threatening conditions depending on its size and location. This article reports a rare case of surgical treatment of an invasive lipoma of the right atrium. AbstractThe aim of this research is to demonstrate a rare case of surgical treatment of an invasive lipoma of the right atrium. Patient Ya., female, 46 years old, was admitted to the department with periodic attacks of rapid arrhythmic heartbeat. ECG: the rhythm is regular, sinus, 79 beats/min heart rate. According to transthoracic echocardiography: an additional floating heterogeneous formation of a round shape with an uneven contour, measuring 32 × 29 mm, attached to the junction of the superior vena cava was visualized and it was placed in the cavity of the right atrium. According to the results of CT and MRI with contrast the cardiac tumor growing into the right atrium wall and extracardially was also visualized. An operation was performed to remove the cardiac tumor of the right atrium, to reconstruct the right atrium with a xenopericardial patch and de Vega tricuspid valve annuloplasty on the beating heart with cardiopulmonary bypass (77 minutes). The size of the outer part of the tumor was 30 × 70 mm, the inner – 40 × 50 mm. The postoperative period proceeded without complications. Microscopic examination of cardiac tumor showed a histological picture of a cardiac lipoma. In conclusion, it should be noted that invasive lipoma of the right atrium is a rare benign tumor of the heart and this research is of scientific interest for the further study of this phenomenon. Early surgical removal of the lipoma is important, taking into account its characteristics, due to the possible risk of tumor growth and infiltration into the surrounding structure. Preoperative planning requires accurate data on the location of the tumor and its infiltration into the adjacent heart structure.
- Open Access
- 30 August 2024
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 28 (2) , 30-40
Pre- and postoperative risk factors for hospital complications upon atypically localized left atrial myxomas
Introduction: Cardiac myxoma is the most common of the benign heart tumor. In the left atrium, it is typically located in the interatrial septum in the area of the fossa ovale; any other its localization is considered atypical. The consequences of surgical treatment of typical myxomas have been sufficiently examined; however, there are no data on treatment of atypically localized left atrium myxomas. Objective: The study is aimed to analyzing the results of surgical intervention upon atypically localized left atrium myxomas and assessing of pre- and postoperative risk factors for adverse hospital events as well as embolic complications. Methods: A retrospective review of the results upon surgical treatment of atypically localized left atrial myxomas (n = 52) through the period from 2008 to 2022 was performed.Results: Non-lethal in-hospital complications are revealed in 15 patients (29%). In-hospital mortality is 6% (n = 3). A comparative analysis of transthoracic echocardiography data, collected before surgical intervention and at the time of hospital discharge, demonstrated a decrease in the left ventricular end diastolic volume and in the left atrial dimensions (P < 0.001). Risk factors for non-lethal in-hospital complications are related to the chronic heart failure NYHA 3 (P < 0.01) and EuroSCORE II (P = 0.03). Risk factors for hospital mortality are associated with advanced age (P = 0.03) and EuroSCORE II (P = 0.03). Preoperative embolic complications are attributed to localization of myxoma on the posterior wall of the left atrium (P = 0.02), villous myxoma (P < 0.001), myxoma prolapse into the left ventricle cavity (P = 0.05).Conclusion: The presented results of surgical treatment of atypically localized left atrium myxomas are comparable to the data of the world literature, including hospital mortality rates (6%). Preoperative risk factors for non-lethal complications are related to chronic heart failure NYHA 3 and EuroSCORE II; for lethal complications they are associated with the age of patients over 65 years and EuroSCORE II. No significant effect of postoperative risk factors on lethal and non-lethal hospital complications was revealed. Received 3 May 2023. Revised 16 April 2024. Accepted 4 June 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: T.A. Simonyan, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanData collection and analysis: T.A. Simonyan, I.M. Tsiskaridze, I.Yu. Farulova, L.V. Spirin, M.S. IbragimovStatistical analysis: T.A. Simonyan, I.M. TsiskaridzeDrafting the article: T.A. Simonyan, I.M. TsiskaridzeCritical revision of the article: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanFinal approval of the version to be published: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. Kakhktsyan, I.Yu. Farulova, L.V. Spirin, M.S. Ibragimov
- 30 August 2024
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 28 (2) , 30-40
Open AccessPre- and postoperative risk factors for hospital complications upon atypically localized left atrial myxomas
Introduction: Cardiac myxoma is the most common of the benign heart tumor. In the left atrium, it is typically located in the interatrial septum in the area of the fossa ovale; any other its localization is considered atypical. The consequences of surgical treatment of typical myxomas have been sufficiently examined; however, there are no data on treatment of atypically localized left atrium myxomas. Objective: The study is aimed to analyzing the results of surgical intervention upon atypically localized left atrium myxomas and assessing of pre- and postoperative risk factors for adverse hospital events as well as embolic complications. Methods: A retrospective review of the results upon surgical treatment of atypically localized left atrial myxomas (n = 52) through the period from 2008 to 2022 was performed.Results: Non-lethal in-hospital complications are revealed in 15 patients (29%). In-hospital mortality is 6% (n = 3). A comparative analysis of transthoracic echocardiography data, collected before surgical intervention and at the time of hospital discharge, demonstrated a decrease in the left ventricular end diastolic volume and in the left atrial dimensions (P < 0.001). Risk factors for non-lethal in-hospital complications are related to the chronic heart failure NYHA 3 (P < 0.01) and EuroSCORE II (P = 0.03). Risk factors for hospital mortality are associated with advanced age (P = 0.03) and EuroSCORE II (P = 0.03). Preoperative embolic complications are attributed to localization of myxoma on the posterior wall of the left atrium (P = 0.02), villous myxoma (P < 0.001), myxoma prolapse into the left ventricle cavity (P = 0.05).Conclusion: The presented results of surgical treatment of atypically localized left atrium myxomas are comparable to the data of the world literature, including hospital mortality rates (6%). Preoperative risk factors for non-lethal complications are related to chronic heart failure NYHA 3 and EuroSCORE II; for lethal complications they are associated with the age of patients over 65 years and EuroSCORE II. No significant effect of postoperative risk factors on lethal and non-lethal hospital complications was revealed. Received 3 May 2023. Revised 16 April 2024. Accepted 4 June 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: T.A. Simonyan, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanData collection and analysis: T.A. Simonyan, I.M. Tsiskaridze, I.Yu. Farulova, L.V. Spirin, M.S. IbragimovStatistical analysis: T.A. Simonyan, I.M. TsiskaridzeDrafting the article: T.A. Simonyan, I.M. TsiskaridzeCritical revision of the article: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanFinal approval of the version to be published: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. Kakhktsyan, I.Yu. Farulova, L.V. Spirin, M.S. Ibragimov
- Open Access
- 28 December 2021
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 25 (4) , 118-123
Surgical management of biatrial myxoma: case report
Heart tumours account for approximately 0.2 % of all tumours: of these, approximately 75 % of all primary heart tumours are benign and 50 % of them are myxomas. Further, myxomas make up 0.0017 % of the general population of patients with cardiovascular disease. Biatrial myxomas, i.e. tumours in both the left and right atria, can be in the form of a ‘butterfly’ or a ‘dumbbell’, and account for < 1 % of all cardiac myxomas. Here we describe the successful surgical management of a rare case of a large biatrial myxoma and concomitant atrioventricular valve insufficiency. Briefly, 2D transthoracic echocardiography findings included an end-diastolic volume of 90 ml, an end-systolic volume of 40 ml and a left ventricular ejection fraction of 55 % (according to Simpson). The fibrous ring of the mitral valve measured 36 mm with a regurgitation degree of 2 while the fibrous ring of the tricuspid valve was 42 mm in size and the regurgitation grade was 3. Lesion size in the cavity of the left and right atrium were 73 × 38 mm and 80 × 42 mm, respectively. These neoplasia were surgically removed under peripheral cardiopulmonary bypass, hypothermia and cold cardioplegia (Custodiol). The myxomas were accessed through the right atrium, according to Giradon and were resected without defragmentation. Next, mitral valve plasty using a soft support ring and annuloplasty of the tricuspid valve were performed according to de Vega. The duration of artificial circulation was 150 minutes and that of myocardial ischaemia was 100 minutes. The patient was extubated 11 hours after surgery, spent 22 hours in the intensive care unit and was discharged on the 14th day after surgery. Surgical resection of biatrial myxomas before the development of serious irreversible or life-threatening complications can provide rapid symptomatic relief in congestive heart failure.Received 30 May 2021. Revised 22 August 2021. Accepted 23 August 2021.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authors Literature review: T.A. Simonyan Drafting the article: T.A. Simonyan, I.M. Tsiskaridze Critical revision of the article: T.A. Simonyan, I.Yu. Farulova, E.A. Babajanyan Surgical treatment: I.I. Scopin, I.M. Tsiskaridze Final approval of the version to be published: T.A. Simonyan, I.I. Scopin, I.M. Tsiskaridze, I.Yu. Farulova, E.A. Babajanyan
- 28 December 2021
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 25 (4) , 118-123
Open AccessSurgical management of biatrial myxoma: case report
Heart tumours account for approximately 0.2 % of all tumours: of these, approximately 75 % of all primary heart tumours are benign and 50 % of them are myxomas. Further, myxomas make up 0.0017 % of the general population of patients with cardiovascular disease. Biatrial myxomas, i.e. tumours in both the left and right atria, can be in the form of a ‘butterfly’ or a ‘dumbbell’, and account for < 1 % of all cardiac myxomas. Here we describe the successful surgical management of a rare case of a large biatrial myxoma and concomitant atrioventricular valve insufficiency. Briefly, 2D transthoracic echocardiography findings included an end-diastolic volume of 90 ml, an end-systolic volume of 40 ml and a left ventricular ejection fraction of 55 % (according to Simpson). The fibrous ring of the mitral valve measured 36 mm with a regurgitation degree of 2 while the fibrous ring of the tricuspid valve was 42 mm in size and the regurgitation grade was 3. Lesion size in the cavity of the left and right atrium were 73 × 38 mm and 80 × 42 mm, respectively. These neoplasia were surgically removed under peripheral cardiopulmonary bypass, hypothermia and cold cardioplegia (Custodiol). The myxomas were accessed through the right atrium, according to Giradon and were resected without defragmentation. Next, mitral valve plasty using a soft support ring and annuloplasty of the tricuspid valve were performed according to de Vega. The duration of artificial circulation was 150 minutes and that of myocardial ischaemia was 100 minutes. The patient was extubated 11 hours after surgery, spent 22 hours in the intensive care unit and was discharged on the 14th day after surgery. Surgical resection of biatrial myxomas before the development of serious irreversible or life-threatening complications can provide rapid symptomatic relief in congestive heart failure.Received 30 May 2021. Revised 22 August 2021. Accepted 23 August 2021.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authors Literature review: T.A. Simonyan Drafting the article: T.A. Simonyan, I.M. Tsiskaridze Critical revision of the article: T.A. Simonyan, I.Yu. Farulova, E.A. Babajanyan Surgical treatment: I.I. Scopin, I.M. Tsiskaridze Final approval of the version to be published: T.A. Simonyan, I.I. Scopin, I.M. Tsiskaridze, I.Yu. Farulova, E.A. Babajanyan